Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.

TL, Smith; ML, Pearson; KR, Wilcox; C, Cruz; MV, Lancaster; B, Robinson-Dunn; FC, Tenover; MJ, Zervos; JD, Band; E, White; WR, Jarvis

doi:10.1056/nejm199902183400701

Public

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.

Shared by NobleBlocks on Feb 1, 1999 • 12:00 AM UTC

Authors:

Smith TL

Pearson ML

Wilcox KR

Abstract

Background Since the emergence of methicillin-resistant Staphylococcus aureus, the glycopeptide vancomycin has been the only uniformly effective treatment for staphylococcal infections. In 1997, two infections due to S. aureus with reduced susceptibility to vancomycin were identified in the United S...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!